Abstract | OBJECTIVES: This study developed a novel MRD monitoring method targeting Wilms' tumor gene (WT1) mRNA using reverse transcription loop-mediated isothermal amplification (RT-LAMP). DESIGN AND METHODS: A primer set for the assay was designed on the basis of the sequences between the 17AA and KTS regions of WT1mRNA. WT1 mRNA was quantified by real-time RT-LAMP and the accuracy of RT-LAMP was compared with that of real-time RT-PCR. RESULTS: The standard curve was expressed as a linear relationship between the log copy numbers of WT1 mRNA ranging from 6.8 x 10 to 6.8 x 10(9) copies and the threshold time with a correlation coefficient of R(2) > 0.994. The measured values obtained by RT-LAMP strongly correlated with those obtained by real-time RT-PCR. CONCLUSION: RT-LAMP can be used to determine WT1 mRNA expression levels. This assay will contribute to a more specific, simple, and rapid MRD monitoring than conventional assays.
|
Authors | Soji Morishita, Hidenori Tani, Shinya Kurata, Kazunori Nakamura, Satoshi Tsuneda, Yuji Sekiguchi, Naohiro Noda |
Journal | Clinical biochemistry
(Clin Biochem)
Vol. 42
Issue 6
Pg. 515-20
(Apr 2009)
ISSN: 1873-2933 [Electronic] United States |
PMID | 19297684
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA Primers
- RNA, Messenger
|
Topics |
- Base Sequence
- DNA Primers
- Gene Expression
- Genes, Wilms Tumor
- Humans
- Leukemia
(diagnosis, genetics)
- Molecular Sequence Data
- Neoplasm, Residual
- Prognosis
- RNA, Messenger
(analysis)
- Reverse Transcriptase Polymerase Chain Reaction
(methods)
- Sensitivity and Specificity
|